Rosa, L.M.M. and Araújo Siega, M.R. de 2022. High-frequency migraine refractory to usual pharmacological treatment and antibody and responsive to full-spectrum cannabidiol: a case report. Headache Medicine. 13, 3 (Sep. 2022), 229–232. DOI:https://doi.org/10.48208/HeadacheMed.2022.26.